Chongqing Zhifei Biological Products Co., Ltd. (SHE:300122)
China flag China · Delayed Price · Currency is CNY
13.54
-0.07 (-0.51%)
Nov 17, 2026, 3:04 PM CST

SHE:300122 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Net Income
-14,079-14,7231,9728,0707,53910,209
Depreciation & Amortization
511.88511.88395.13323.71314.94375.85
Other Amortization
22.5822.5816.4314.6815.8913.01
Loss (Gain) From Sale of Assets
-5.88-5.88-0.05-41.37-0.01-0.04
Asset Writedown & Restructuring Costs
0.380.380.360.130.091.68
Loss (Gain) From Sale of Investments
-0.12-0.12-0.28--20.03
Provision & Write-off of Bad Debts
464.65464.65606.88352.59420.87190.74
Other Operating Activities
14,26513,976175.95394.49166.06134.48
Change in Accounts Receivable
4,9074,90710,155-6,756-8,056-6,546
Change in Inventory
3,6223,622-13,275-1,313-765.61-3,982
Change in Accounts Payable
-868.54-868.54-3,8858,3382,4138,064
Operating Cash Flow
6,1015,167-4,2248,9961,9898,508
Operating Cash Flow Growth
256.55%--352.30%-76.62%143.30%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Capital Expenditures
-451.16-619.19-1,201-1,134-1,453-1,932
Sale of Property, Plant & Equipment
0.176.944.76168.070.650.32
Investment in Securities
-14.995.65--10.5-45.5-69
Other Investing Activities
-0.2811.65-7.5---18.55
Investing Cash Flow
-466.27-594.94-1,204-976.6-1,498-2,019

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Short-Term Debt Issued
---5.5439.0894.63
Long-Term Debt Issued
-13,34814,8676,3425,4772,569
Total Debt Issued
8,37113,34814,8676,3485,5172,663
Short-Term Debt Repaid
--86.52-1.55-0.39-18.64-75.01
Long-Term Debt Repaid
--17,641-10,199-9,739-6,643-5,312
Total Debt Repaid
-13,888-17,727-10,200-9,739-6,661-5,387
Net Debt Issued (Repaid)
-5,517-4,3794,667-3,391-1,145-2,723
Repurchase of Common Stock
---300.03---
Common Dividends Paid
-367.4-344.81-2,564-889.29-1,015-861.96
Other Financing Activities
-626.4-8.49-15.21-13.08-12.82-4.76
Financing Cash Flow
-6,511-4,7331,788-4,294-2,173-3,590

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Foreign Exchange Rate Adjustments
-0.94-0.691.25-2.317.56-9.66
Net Cash Flow
-877.3-161.11-3,6393,724-1,6642,889

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Free Cash Flow
5,6504,548-5,4257,862535.936,575
Free Cash Flow Growth
520.23%--1367.02%-91.85%146.30%
Free Cash Flow Margin
71.95%50.77%-20.83%14.86%1.40%21.45%
Free Cash Flow Per Share
2.361.90-2.273.280.222.74
Levered Free Cash Flow
11,3037,435-10,5351,494-3,9312,887
Unlevered Free Cash Flow
11,5087,642-10,4341,545-3,8982,922

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Cash Income Tax Paid
275.74443.942,0743,3103,2741,955
Change in Working Capital
4,9214,921-7,391-117.72-6,468-2,437